Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the HR gene is linked to a rare form of hair loss with limb deformities.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Justicia procumbens extract may help prevent hair loss and improve hair thickness and shine in a type of hair loss condition.

The treatment led to denser, thicker hair growth and less hair loss.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Nutritional supplements may help improve hair growth in female pattern hair loss.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Uncombable hair syndrome causes frizzy hair and can affect the nervous system, eyes, and ears, often co-occurring with other hair, skin, nail, and teeth conditions, and is linked to three specific gene mutations.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.